Mokari Atabak — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Mokari Atabak has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.05M.

Profile

Mokari Atabak

Atabak Mokari is the Chief Financial Officer of Corcept Therapeutics Inc, a company focused on developing medications that modulate cortisol for various serious disorders. He has been involved in multiple SEC filings related to his role at the company.

RoleInsider
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-17CORTCORCEPT THERAPEUTICS INCS — Open-market sale2$82.45$165
2026-06-17CORTCORCEPT THERAPEUTICS INCS — Open-market sale19.5K$81.81$1.59M
2026-06-17CORTCORCEPT THERAPEUTICS INCS — Open-market sale11.1K$80.94$897K
2026-06-17CORTCORCEPT THERAPEUTICS INCS — Open-market sale9.4K$80.02$755K
2026-06-17CORTCORCEPT THERAPEUTICS INCM — Option exercise40.0K$19.26$770K
2026-06-03CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture395$70.44$28K
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award634$0.00
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award634$70.44$45K
2026-06-03CORTCORCEPT THERAPEUTICS INCS — Open-market sale40.0K$70.00$2.80M
2026-06-03CORTCORCEPT THERAPEUTICS INCM — Option exercise40.0K$19.26$770K
2026-03-05CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture96$35.97$3K
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award397$0.00
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award397$35.97$14K
2025-12-04CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture118$79.78$9K
2025-12-04CORTCORCEPT THERAPEUTICS INCA — Grant or award178$0.00
2025-12-04CORTCORCEPT THERAPEUTICS INCA — Grant or award178$79.78$14K
2025-09-02CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture144$71.38$10K
2025-09-02CORTCORCEPT THERAPEUTICS INCA — Grant or award200$0.00
2025-09-02CORTCORCEPT THERAPEUTICS INCA — Grant or award200$71.38$14K
2025-06-02CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture519$71.68$37K

Companies — Last 90 Days

Frequently Asked Questions

Who is Mokari Atabak?

Atabak Mokari is the Chief Financial Officer of Corcept Therapeutics Inc, a company focused on developing medications that modulate cortisol for various serious disorders. He has been involved in multiple SEC filings related to his role at the company.…

How many SEC Form 4 filings has Mokari Atabak submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Mokari Atabak been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($6.05M) across all tracked filings.

Where can I see all of Mokari Atabak's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Mokari Atabak profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.